![Detlev Biniszkiewicz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Detlev Biniszkiewicz
Directeur Général chez
Rekindle Therapeutics, Inc.
Profil
Dr. Detlev Biniszkiewicz is a Chairman at Nextpoint Therapeutics, Inc., a President, Chief Executive Officer & Director at Rekindle Therapeutics, Inc. and a Managing Director at MPM BioImpact LLC.
He is on the Board of Directors at Rekindle Therapeutics, Inc. and Maverick Therapeutics, Inc.
Dr. Biniszkiewicz was previously employed as an Independent Director by iTeos Therapeutics, Inc., a President & Director by Surface Oncology, Inc., a Vice President-Oncology Strategy by AstraZeneca Diagnostics, and a Principal by The Boston Consulting Group, Inc. He also served on the board at Tilos Therapeutics, Inc.
He received his undergraduate degree from Julius-Maximilians-Universität Würzburg, a graduate degree from Julius-Maximilians-Universität Würzburg and a doctorate degree from Massachusetts Institute of Technology.
Postes actifs de Detlev Biniszkiewicz
| Sociétés | Poste | Début |
|---|---|---|
Rekindle Therapeutics, Inc.
 Rekindle Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an biotechnology company | Directeur Général | 01/12/2018 |
Nextpoint Therapeutics, Inc.
 Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates life sciences research and development company | Président | 01/02/2024 |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Directeur/Membre du Conseil | - |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 01/01/2018 |
Anciens postes connus de Detlev Biniszkiewicz
| Sociétés | Poste | Fin |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 13/06/2023 |
Tilos Therapeutics, Inc.
 Tilos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for cancer, fibrosis and autoimmune disease | Directeur/Membre du Conseil | 01/01/2020 |
AstraZeneca Diagnostics | Corporate Officer/Principal | 01/04/2015 |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Private Equity Investor | 01/01/2007 |
| SURFACE ONCOLOGY, INC. | Directeur Général | 01/09/2017 |
Formation de Detlev Biniszkiewicz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
AstraZeneca Diagnostics | |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Tilos Therapeutics, Inc.
Tilos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for cancer, fibrosis and autoimmune disease | Health Technology |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Health Technology |
Rekindle Therapeutics, Inc.
Rekindle Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an biotechnology company | Commercial Services |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates life sciences research and development company | Commercial Services |
